日本語English简体中文 繁體中文

4576 D.Western Therapeutics Institute, Inc.デ・ウエスタン・セラピテクス研究所TSE Growth / Pharmaceuticals

0 posts

D.Western Therapeutics Institute, Inc. (4576) at a glance

Code
4576
Company
D.Western Therapeutics Institute, Inc.
Local name
デ・ウエスタン・セラピテクス研究所
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥45.0 -3.00 (-6.25%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

D.Western Therapeutics Institute, Inc. (4576) Stock Price HistoryNear an all-time low

D.Western Therapeutics Institute, Inc. closed at ¥45.0 on Nov 20, 2026, −30.8% over 1 month, −53.6% over 1 year.

2026-11-12 2026年12月期 第3四半期決算短信〔日本基準〕(連結)¥66.0¥45.0Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥66.0Oct 21
1-Month Low¥45.0Nov 20
1-Week Change−10.0%vs Nov 13
1-Month Change−30.8%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥69,231 today (−30.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −30.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥45.0−3−6.25%
Nov 19 (Thu)¥48.0+1+2.13%
Nov 18 (Wed)¥47.0−1−2.08%
Nov 17 (Tue)¥48.0+1+2.13%
Nov 16 (Mon)¥47.0−3−6.00%
Nov 13 (Fri)¥50.0+1+2.04%
Nov 12 (Thu)¥49.0−2−3.92%
Nov 11 (Wed)¥51.0+1+2.00%
Nov 10 (Tue)¥50.0+0+0.00%
Nov 6 (Fri)¥50.0−4−7.41%
2026-09-14 第13回新株予約権の取得・消却並びに第三者割当てによる第14回新株予約権(行使価額…2026-10-01 第三者割当てによる第14回新株予約権(行使価額修正条項付)及び第2回無担保社債の…2026-11-12 2026年12月期 第3四半期決算短信〔日本基準〕(連結)¥89.0¥45.0Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥89.0Aug 24
3-Month Low¥45.0Nov 20
1-Month Change−30.8%vs Oct 20
3-Month Change−48.9%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥51,136 today (−48.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −48.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥45.0−3−6.25%
Nov 19 (Thu)¥48.0+1+2.13%
Nov 18 (Wed)¥47.0−1−2.08%
Nov 17 (Tue)¥48.0+1+2.13%
Nov 16 (Mon)¥47.0−3−6.00%
Nov 13 (Fri)¥50.0+1+2.04%
Nov 12 (Thu)¥49.0−2−3.92%
Nov 11 (Wed)¥51.0+1+2.00%
Nov 10 (Tue)¥50.0+0+0.00%
Nov 6 (Fri)¥50.0−4−7.41%
2026-09-14 第13回新株予約権の取得・消却並びに第三者割当てによる第14回新株予約権(行使価額…2026-10-01 第三者割当てによる第14回新株予約権(行使価額修正条項付)及び第2回無担保社債の…2026-11-12 2026年12月期 第3四半期決算短信〔日本基準〕(連結)¥89.0¥45.0May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥89.0Aug 24
6-Month Low¥45.0Nov 20
3-Month Change−48.9%vs Aug 20
6-Month Change−42.3%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥57,692 today (−42.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −42.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥45.0−23.7%
Oct 2026¥59.0−23.4%
Sep 2026¥77.0−13.5%
Aug 2026¥89.0+17.1%
Jul 2026¥76.0+2.7%
Jun 2026¥74.0−2.6%
May 2026¥76.0−15.6%
2026-09-14 第13回新株予約権の取得・消却並びに第三者割当てによる第14回新株予約権(行使価額…2026-10-01 第三者割当てによる第14回新株予約権(行使価額修正条項付)及び第2回無担保社債の…2026-11-12 2026年12月期 第3四半期決算短信〔日本基準〕(連結)¥107¥45.0Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥107Nov 28
52-Week Low¥45.0Nov 20
Year to Date−53.1%vs Dec 30
From 52-Week High−57.9%Nov 28

If you had invested ¥100,000 1 year ago, it would be worth ¥46,392 today (−53.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −53.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥45.0−23.7%
Oct 2026¥59.0−23.4%
Sep 2026¥77.0−13.5%
Aug 2026¥89.0+17.1%
Jul 2026¥76.0+2.7%
Jun 2026¥74.0−2.6%
May 2026¥76.0−15.6%
Apr 2026¥90.0−2.2%
Mar 2026¥92.0−11.5%
Feb 2026¥104+2.0%
Jan 2026¥102+6.3%
Dec 2025¥96.0−10.3%
Nov 2025¥107―
¥225¥45.0Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥225Dec 16, 2024
3-Year Low¥45.0Nov 20, 2026
Annualized Return−35.0%
Max Drawdown−80.0%

If you had invested ¥100,000 3 years ago, it would be worth ¥27,439 today (−72.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −72.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥45.0−53.1%
2025¥96.0―
¥340¥45.0Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥340Oct 24, 2022
5-Year Low¥45.0Nov 20, 2026
Annualized Return−30.8%
Max Drawdown−86.8%

If you had invested ¥100,000 5 years ago, it would be worth ¥15,901 today (−84.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −84.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥45.0−53.1%
2025¥96.0―
¥2,608¥45.0Nov 1, 2009Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,608Jul 2014
All-Time Low¥45.0Nov 2026
Total Change−78.4%vs Nov 2009
Annualized Return−8.6%

If you had invested ¥100,000 in Nov 2009, it would be worth ¥21,635 today (−78.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +435.1%, while this stock moved −78.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥45.0−53.1%
2025¥96.0−52.2%
2024¥201+42.6%
2023¥141−46.2%
2022¥262+21.3%
2021¥216−25.3%
2020¥289−55.5%
2019¥649+13.1%
2018¥574+12.1%
2017¥512+25.5%
2016¥408−26.5%
2015¥555−47.4%
2014¥1,055+17.5%
2013¥898+596.1%
2012¥129+13.2%
2011¥114−18.0%
2010¥139−34.1%
2009¥211―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2009). Please check the latest prices before trading.

D.Western Therapeutics Institute, Inc. (4576) financial indicators

PBR
2.09
ROE
-68.61%
Dividend yield
0.00%

See all financial indicators for D.Western Therapeutics Institute, Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of D.Western Therapeutics Institute, Inc. (4576)

Business overview

Together with consolidated subsidiary 「日本革新創薬」 (JIT), the company runs a drug discovery business that researches and develops pharmaceuticals centered on protein kinase inhibitors and earns revenue by licensing out its development candidates to pharmaceutical companies and others. In drug development, costs rise sharply as development moves from non-clinical to clinical trials, and a clinical development organization of a certain size becomes necessary. The company licenses out candidates at a relatively early stage, letting pharmaceutical companies strong in clinical development carry development forward, which keeps its own structure low-cost. It attributes its ability to license out early to its own technical strength in basic research and the efficient R&D that makes use of it. Revenue mainly consists of upfront payments at licensing, milestone payments at each development stage and royalties based on sales after launch.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.09xAbove the sector median of 1.86x (No. 44 from the lowest)
ROE-68.61%No. 49 in the sector (highest first); median 4.17%
Market cap¥2.6 bnNo. 74 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1072025/12/4
52-week low¥4511/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥45)
Year to date-53.1%No. 69 of 77 in the sector (best first)
1 year-53.6%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers1 timesLatest: 9/29 (No. 29)
Top 50 losers1 timesLatest: 11/4 (No. 50)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (9).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the D.Western Therapeutics Institute, Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English